Posted by Michael Wonder on 15 Sep 2020
Rep Grothman introduces bill for automatic insulin biosimilar interchangeablity
15 September 2020 - Representative Glenn Grothman, (R-Wisconsin), says interchangeability for insulins makes sense based on the savings potential and safety record of these agents.
A new bill (HR 8190) introduced in the House of Representatives would allow for biosimilar insulins to automatically be granted interchangeability designations.
Interchangeable status enables prescriptions to be filled with lower-cost biosimilars, without a prescribing physician’s authorisation.
